These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 16905754)

  • 1. Postoperative radiotherapy for patients with prostate cancer in Japan; Changing trends in national practice between 1996-98 and 1999-2001: Patterns of care study for prostate cancer.
    Sasaki T; Nakamura K; Ogawa K; Onishi H; Otani Y; Koizumi M; Shioyama Y; Teshima T;
    Jpn J Clin Oncol; 2006 Oct; 36(10):649-54. PubMed ID: 16905754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low pre-radiotherapy prostate-specific antigen level is a significant predictor of treatment success for postoperative radiotherapy in patients with prostate cancer.
    Sasaki T; Nakamura K; Shioyama Y; Ohga S; Toba T; Urashima Y; Yoshitake T; Terashima H; Koga H; Naito S; Noma H; Komatsu K; Yamaguchi A; Hiratsuka Y; Hirano T; Hanada K; Abe M; Fujisawa Y; Honda H
    Anticancer Res; 2006; 26(3B):2367-74. PubMed ID: 16821618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radical external beam radiotherapy for clinically localized prostate cancer in Japan: changing trends in the patterns of care process survey between 1996-1998 and 1999-2001.
    Ogawa K; Nakamura K; Onishi H; Sasaki T; Koizumi M; Shioyama Y; Komiyama T; Miyabe Y; Teshima T;
    Anticancer Res; 2005; 25(5):3507-11. PubMed ID: 16101170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved outcomes with higher doses for salvage radiotherapy after prostatectomy.
    King CR; Spiotto MT
    Int J Radiat Oncol Biol Phys; 2008 May; 71(1):23-7. PubMed ID: 18207668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radical external beam radiotherapy for prostate cancer in Japan: results of the 1999-2001 patterns of care process survey.
    Ogawa K; Nakamura K; Onishi H; Sasaki T; Koizumi M; Shioyama Y; Komiyama T; Miyabe Y; Teshima T;
    Jpn J Clin Oncol; 2006 Jan; 36(1):40-5. PubMed ID: 16418185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of care in the radiotherapy of prostate cancer in Northern Bavaria 1998-2000.
    Vordermark D; Marold D; Wirth S; Keilholz L; Pfändner K; Schimpke T; Thiel HJ; Willner J; Ziegler K; Guckenberger M; Flentje M
    Strahlenther Onkol; 2007 Jun; 183(6):314-20. PubMed ID: 17520185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radical external beam radiotherapy for clinically localized prostate cancer in Japan: differences in the patterns of care between Japan and the United States.
    Ogawa K; Nakamura K; Onishi H; Sasaki T; Koizumi M; Shioyama Y; Komiyama T; Miyabe Y; Teshima T;
    Anticancer Res; 2006; 26(1B):575-80. PubMed ID: 16739323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Need for high radiation dose (>or=70 gy) in early postoperative irradiation after radical prostatectomy: a single-institution analysis of 334 high-risk, node-negative patients.
    Cozzarini C; Montorsi F; Fiorino C; Alongi F; Bolognesi A; Da Pozzo LF; Guazzoni G; Freschi M; Roscigno M; Scattoni V; Rigatti P; Di Muzio N
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):966-74. PubMed ID: 19619960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postoperative prostate-specific antigen velocity independently predicts for failure of salvage radiotherapy after prostatectomy.
    King CR; Presti JC; Brooks JD; Gill H; Spiotto MT
    Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1472-7. PubMed ID: 17935902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sooner or later? Outcome analysis of 431 prostate cancer patients treated with postoperative or salvage radiotherapy.
    Jereczek-Fossa BA; Zerini D; Vavassori A; Fodor C; Santoro L; Minissale A; Cambria R; Cattani F; Garibaldi C; Serafini F; Matei VD; de Cobelli O; Orecchia R
    Int J Radiat Oncol Biol Phys; 2009 May; 74(1):115-25. PubMed ID: 19004572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radical external beam radiotherapy for clinically localized prostate cancer in Japan: changing trends in the patterns of care process survey.
    Ogawa K; Nakamura K; Sasaki T; Onishi H; Koizumi M; Araya M; Mukumoto N; Teshima T; Mitsumori M;
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1310-8. PubMed ID: 20950959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiotherapy for patients with localized hormone-refractory prostate cancer: results of the Patterns of Care Study in Japan.
    Sasaki T; Nakamura K; Ogawa K; Onishi H; Okamoto A; Koizumi M; Shioyama Y; Mitsumori M; Teshima T;
    BJU Int; 2009 Nov; 104(10):1462-6. PubMed ID: 19522869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does neoadjuvant hormone therapy improve outcome in prostate cancer patients receiving radiotherapy after radical prostatectomy?
    Pai HH; Eldridge B; Bishop D; Alexander A; Lesperance M; Blood P; Lim J; Ludgate C
    Can J Urol; 2009 Apr; 16(2):4541-52. PubMed ID: 19364426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Achieving an undetectable PSA after radiotherapy for biochemical progression after radical prostatectomy is an independent predictor of biochemical outcome--results of a retrospective study.
    Wiegel T; Lohm G; Bottke D; Höcht S; Miller K; Siegmann A; Schostak M; Neumann K; Hinkelbein W
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1009-16. PubMed ID: 18963539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized trial comparing radical prostatectomy plus endocrine therapy versus external beam radiotherapy plus endocrine therapy for locally advanced prostate cancer: results at median follow-up of 102 months.
    Akakura K; Suzuki H; Ichikawa T; Fujimoto H; Maeda O; Usami M; Hirano D; Takimoto Y; Kamoto T; Ogawa O; Sumiyoshi Y; Shimazaki J; Kakizoe T;
    Jpn J Clin Oncol; 2006 Dec; 36(12):789-93. PubMed ID: 17082219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformal radiotherapy for detectable PSA following radical prostatectomy: efficacy and predictive factors of recurrence.
    Delongchamps NB; Zerbib M; Mejean A; Rouach Y; Debre B; Peyromaure M
    Can J Urol; 2009 Oct; 16(5):4813-9. PubMed ID: 19796456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of post-prostatectomy radiotherapy in one institution.
    Borg M; Sutherland P; Stapleton A; Bolt J; Steele D; Landers B; Porter A; Buxton S; Heilbornn C; Wong HZ
    Australas Radiol; 2006 Oct; 50(5):475-80. PubMed ID: 16981946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95.
    Wiegel T; Bottke D; Steiner U; Siegmann A; Golz R; Störkel S; Willich N; Semjonow A; Souchon R; Stöckle M; Rübe C; Weissbach L; Althaus P; Rebmann U; Kälble T; Feldmann HJ; Wirth M; Hinke A; Hinkelbein W; Miller K
    J Clin Oncol; 2009 Jun; 27(18):2924-30. PubMed ID: 19433689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in patterns of care for limited-stage small-cell lung cancer: results of the 99-01 patterns of care study-a nationwide survey in Japan.
    Uno T; Sumi M; Ishihara Y; Numasaki H; Mitsumori M; Teshima T;
    Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):414-9. PubMed ID: 18164865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy.
    Da Pozzo LF; Cozzarini C; Briganti A; Suardi N; Salonia A; Bertini R; Gallina A; Bianchi M; Fantini GV; Bolognesi A; Fazio F; Montorsi F; Rigatti P
    Eur Urol; 2009 May; 55(5):1003-11. PubMed ID: 19211184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.